Parallax Volatility Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Parallax Volatility Advisers’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-479	Closed	-$10K	–	4152
2018 Q3	$10K	Buy	+479	New	+$14.6K	﹤0.01%	2246
2018 Q1	–	Sell	-495	Closed	-$36K	–	4543
2017 Q4	$36K	Buy	+495	New	+$40.9K	﹤0.01%	3392

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallax Volatility Advisers's LUMO Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 479 shares — an estimated $10K sold.

Parallax Volatility Advisers first reported a position in LUMO in Q4 2017 and held it in 2 quarters. The position peaked at $36K in Q4 2017. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

Parallax Volatility Advisers reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 479 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $10K.
Parallax Volatility Advisers first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
Parallax Volatility Advisers's Lumos Pharma, Inc. Common Stock position peaked at $36K in Q4 2017.
87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.